HRMY in the 13F filings
Harmony Biosciences HLDGS In · CUSIP 413197104
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 14 Feb 2024
- latest of these filings; the earliest 12 Feb 2024
- Managers listing it
- 4
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 4 listed it in both
- Shares listed
- 723,424
- combined, among listed positions
- Reported value
- $23m
- combined, at the quarter end
Among the 93 comparable managers: 3 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing HRMY in Q4 2023
4 of 4 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Voloridge Investment Management LLC | 411,804 | $13m | 0.05% | Added | +142,637 | 14 Feb 2024 (the filing on sec.gov) |
| Woodline Partners LP | 149,518 | $4.8m | 0.05% | Trimmed | -84,341 | 14 Feb 2024 (the filing on sec.gov) |
| PDT Partners LLC | 92,566 | $3.0m | 0.33% | Added | +36,629 | 14 Feb 2024 (the filing on sec.gov) |
| Winton Group Ltd | 69,536 | $2.2m | 0.16% | Added | +57,438 | 12 Feb 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Voloridge Investment Management LLCexisting position · 411,804 shares now+142,637
- Winton Group Ltdexisting position · 69,536 shares now+57,438
- PDT Partners LLCexisting position · 92,566 shares now+36,629
Reductions
- Woodline Partners LPexisting position · 149,518 shares now-84,341
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2020 | 1 | $3.9m | n.a. | n.a. |
| Q4 2021 | 1 | $66m | n.a. | n.a. |
| Q1 2022 | 2 | $87m | n.a. | n.a. |
| Q2 2022 | 3 | $92m | n.a. | n.a. |
| Q3 2022 | 3 | $93m | n.a. | n.a. |
| Q4 2022 | 5 | $110m | n.a. | n.a. |
| Q1 2023 | 3 | $16m | n.a. | n.a. |
| Q2 2023 | 5 | $35m | n.a. | n.a. |
| Q3 2023 | 5 | $28m | n.a. | n.a. |
| Q4 2023 | 4 | $23m | 3 | 1 |
| Q1 2024 | 2 | $15m | 0 | 2 |
| Q2 2024 | 1 | $2.6m | 0 | 0 |
| Q3 2024 | 2 | $3.4m | 1 | 1 |
| Q4 2024 | 3 | $35m | 2 | 2 |
| Q1 2025 | 3 | $36m | 1 | 2 |
| Q2 2025 | 1 | $38m | 1 | 0 |
| Q3 2025 | 4 | $7.5m | 3 | 0 |
| Q4 2025 | 5 | $111m | 17 | 13 |
| Q1 2026 | 5 | $41m | 21 | 9 |
| Q2 2026 | 3 | $54m | 14 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
HRMY and LLY →HRMY and JNJ →HRMY and VRTX →Choose a stock to compare with HRMY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own HRMY, latest filings →Back to the 13F Explorer →